Showing results (1131-1140 of 2,404) with videos related to

Sort By:
Pageof 241
Physiotherapy Canada. Physiotherapie Canada|May 10, 2024
A Call to Disrupt Heteronormativity and Cisnormativity in Physical Therapy: Perspectives of 2SLGBTQIPA+ Participants on Future Directions for PT CurriculaRoshni Ravi, Sharon Cheng, Jennifer Hutter, et al.
Leukemia|September 28, 2024
Characterization of myeloproliferative neoplasms based on genetics only and prognostication of transformation to blast phaseWencke Walter, Niroshan Nadarajah, Stephan Hutter, et al.
Archives of Biochemistry and Biophysics|December 6, 2019
Novel insights into oxidation of fatty acids and fatty alcohols by cytochrome P450 monooxygenase CYP4B1Florian A Thesseling, Michael C Hutter, Constanze Wiek, et al.
European Journal of Medicinal Chemistry|May 13, 2026
Novel hybrid 1,4-naphthoquinone-endoperoxide antimalarial hits: Synthesis, stereoisomeric separation, and biological evaluationAlexandre Benech, Sébastien Hutter, Nicolas Vanthuyne, et al.
Physical Chemistry Chemical Physics : PCCP|May 16, 2014
Site-selective adsorption of phthalocyanine on h-BN/Rh(111) nanomeshMarcella Iannuzzi, Fabien Tran, Roland Widmer, et al.
Journal of Neural Transmission. Supplementum|November 29, 2002
Vitamin E binding protein afamin protects neuronal cells in vitroM Heiser, B Hutter-Paier, L Jerkovic, et al.
Vaccines|June 25, 2026
Charting the Path Forward for HIV Immune-Based Prevention: Contributions of the Division of AIDS at NIAIDJulia Hutter, M Patricia D'Souza, Janet M McNicholl, et al.
Gene Therapy|June 27, 2001
Standard heparin, low molecular weight heparin, low molecular weight heparinoid, and recombinant hirudin differ in their ability to inhibit transduction by recombinant adeno-associated virus type 2 vectorsU T Hacker, F M Gerner, H Büning, et al.
Journal of the American Chemical Society|July 10, 2003
Photolytic cleavage of 1-(2-nitrophenyl)ethyl ethers involves two parallel pathways and product release is rate-limited by decomposition of a common hemiacetal intermediateJohn E T Corrie, Andreas Barth, V Ranjit N Munasinghe, et al.
Annals of Hematology|January 11, 2012
The proteasome inhibitor bortezomib targets cell cycle and apoptosis and acts synergistically in a sequence-dependent way with chemotherapeutic agents in mantle cell lymphomaGrit Hutter, Malte Rieken, Alessandro Pastore, et al.
Pageof 241